Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints
Launched by ERASMUS MEDICAL CENTER · Apr 25, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Since 2019, the world has been overwhelmed by COVID-19, a respiratory infectious disease. Current evidence suggests that approximately 10%-20% of people experience symptoms of post COVID-19 condition. Many post COVID-19 victims suffer from fatigue, cognitive deficits and / or subjective cognitive complaints, even after 1 year after hospitalization. Detailed research shows deficits in attention, both in sustained and executive components. Furthermore, less capacity of working memory, inhibition deficits and lower information processing speed is frequently reported. Fatigue and cognitive impa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18 years and older;
- • patient has sufficient knowledge of Dutch language;
- • CFQ\> 43 at 2 year follow-up of CO-FLOW, indicating persistent cognitive complaints;
- • Computer and internet-access.
- Exclusion Criteria:
- * A potential participant who meets any of the following criteria will be excluded from participation in this study:
- • Incapacitated patients like patients diagnosed with dementia;
- • Patients should not be involved in concurrent rehabilitation program, cognitive behavioural therapy or psychotherapy targeting cognition, anxiety and/or depression.
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, Zuid Holland, Netherlands
Patients applied
Trial Officials
Gerard Ribbers, Professor
Study Chair
Professor Rehabilitation Medicine and chair of the department
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported